Akinori Hanatani

Title: Akinori Hanatani: Innovator in Transdermal Drug Delivery Systems

Introduction

Akinori Hanatani is a notable inventor based in San Diego, CA. He has made significant contributions to the field of transdermal drug delivery systems, particularly in the treatment of migraines. With a total of 2 patents, Hanatani's work is paving the way for innovative solutions in healthcare.

Latest Patents

One of Hanatani's latest patents is the Triptan microporation delivery system. This transdermal delivery system is designed for the effective delivery of a triptan into the tissue membrane of a subject. The system includes a transdermal microporation apparatus that heats the skin surface and a triptan drug delivery patch. The patch consists of a top layer with adhesive, a middle layer containing the triptan, and a bottom layer. The method for treating a subject involves identifying a patient with a migraine, using the microporation apparatus to create multiple micropores in the skin, and applying the triptan patch over these micropores for a duration sufficient to deliver the triptan effectively.

Career Highlights

Akinori Hanatani is currently associated with Passport Technologies, Inc., where he continues to innovate in the field of drug delivery systems. His work is characterized by a commitment to improving patient outcomes through advanced technology.

Collaborations

Hanatani collaborates with talented individuals such as Hirotoshi Adachi and Shohei Horie, contributing to a dynamic team focused on groundbreaking innovations.

Conclusion

Akinori Hanatani's contributions to transdermal drug delivery systems exemplify the impact of innovative thinking in healthcare. His patents and ongoing work are set to enhance the treatment options available for migraine sufferers.